APSR2026-826

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP12-053
P130
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1218876-46904-APSR2026-826_439797.pdf
Format: PDF Only
16. Interstitial Lung Disease
1

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Sheina Magtuba * Vicente Sotto Memorial Medical Center Regional Lung Center Cebu City Philippines
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Sheina
Magtuba
sheinamagtuba9@gmail.com
+639226427481
31-40
Philippines
Case Report
Treating Beyond Biomarkers: Early Sirolimus Initiation in Suspected Lymphangioleiomyomatosis Despite Non‑Elevated VEGF‑D
Maximum 25 words
Abstract Content
 
 
 
 
Lymphangioleiomyomatosis (LAM) is an uncommon neoplastic cystic lung disease predominantly affecting women of reproductive age. Although vascular endothelial growth factor-D (VEGF-D) is a useful diagnostic adjunct, normal levels do not exclude the disease, necessitating reliance on clinical and radiologic correlation.
A 39-year-old Filipino woman presented with progressive exertional dyspnea initially attributed to asthma. Chest radiograph suggested miliary tuberculosis, but sputum Gene-Xpert was negative. High-resolution chest CT scan revealed innumerable, bilateral, thin-walled cysts diffusely distributed throughout both lungs, highly suggestive of LAM. Pulmonary function tests showed moderate airflow obstruction (FEV₁ 69% predicted) without bronchodilator reversibility and severely reduced diffusing capacity (DLCO 36% predicted). The six-minute walk test demonstrated reduced functional capacity with exertional desaturation to 92%. Abdominal imaging identified a retroperitoneal mass suspicious for angiomyolipoma. Serum VEGF-D was not elevated. Despite this, sirolimus therapy was initiated based on integrated clinical, radiologic, and physiologic evidence, with subsequent symptomatic improvement.
This case highlights the limitations of relying solely on VEGF-D for diagnosis and treatment decisions in LAM. Characteristic CT findings, severe diffusion impairment, and extrapulmonary features provided strong diagnostic confidence despite biomarker negativity. Early sirolimus initiation may be justified in patients with suspected LAM when the overall clinical profile is highly suggestive, even in the absence of elevated VEGF-D.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Lymphangioleiomyomatosis, Diffuse Cystic Lung Disease, Sirolimus
maximum 3 keywords and no abbreviations, separated by commas
 
206